Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 3 Patents
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

16-01-2018 • US-9867830-B2

WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.

SRI International Inc • Cooper Health System Inc • Office of Technology Transfer

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

16-05-2017 • US-9650352-B2

WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.

SRI International Inc • Cooper Health System Inc • US Department of Health and Human Services

Gingerenone A prodrugs as sensotherapeutics and methods of use

10-06-2025 • US-12325688-B2

MOADDEL, RUIN • FERRUCCI, LUIGI • ABDELMOHSEN, KOTB • GOROSPE, MYRIAM • ROSSI, MARTINA • RAMSDEN, CHRISTOPHER E. • KEYES, GREGORY S.

US Department of Health and Human Services

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.